Leadership Overview
Cadila Pharmaceuticals has 10 executives leading key functions including strategy, operations, revenue generation, human resources, and regional markets.
Driven by a commitment to innovation and quality, Cadila Pharmaceuticals is dedicated to advancing healthcare through its comprehensive pharmaceutical operations, impacting global health with its diverse product portfolio.
Driven by a commitment to innovation and quality, Cadila Pharmaceuticals is dedicated to advancing healthcare through its comprehensive pharmaceutical operations, impacting global health with its diverse product portfolio.
Leadership Roles at Cadila Pharmaceuticals
Ajay Trivedi - Chief Executive Officer
Ajay Trivedi, the Chief Executive Officer at Cadila Pharmaceuticals, directs the overarching corporate strategy and operational execution across all business units. Trivedi guides the company's integrated approach, encompassing the manufacturing of APIs, intermediates, finished formulations, OTC food supplements, and biotechnology products. This leadership role involves aligning departmental objectives with the company's mission to deliver high-quality pharmaceutical solutions. Ajay Trivedi ensures that Cadila Pharmaceuticals maintains its competitive edge in the Indian and global markets through strategic decision-making and resource allocation. The Chief Executive Officer's purview extends to fostering innovation and driving sustainable growth across the entire value chain, from research and development to market distribution. This executive's focus remains on enhancing operational efficiency and expanding market reach, solidifying the company's position as a leading pharmaceutical entity.
Kamalesh Kalidasan - Chief Operating Officer
Kamalesh Kalidasan, the Chief Operating Officer at Cadila Pharmaceuticals, oversees the day-to-day operational activities and ensures seamless execution of manufacturing processes. Kalidasan's responsibilities include optimizing production workflows for APIs, intermediates, and finished formulations, maintaining stringent quality control standards. This executive drives efficiency improvements across the company's integrated operations, from raw material sourcing to final product delivery. Kamalesh Kalidasan plays a critical part in managing the supply chain and logistics, ensuring timely availability of products to meet market demands. The Chief Operating Officer's strategic focus is on enhancing manufacturing capabilities and implementing best practices to support Cadila Pharmaceuticals' growth objectives. By streamlining operations, Kalidasan contributes directly to the company's ability to deliver affordable and accessible healthcare solutions.
Mitul Dave - Chief Operating Officer- CSBU
Mitul Dave, the Chief Operating Officer- CSBU at Cadila Pharmaceuticals, manages the operational aspects of the Consumer Self-Care Business Unit (CSBU). Dave directs the production and distribution of OTC food supplements and other consumer health products, ensuring alignment with market needs and regulatory requirements. This role involves optimizing the supply chain specifically for the CSBU, enhancing product availability and customer satisfaction. Mitul Dave focuses on driving operational excellence within this segment, contributing to Cadila Pharmaceuticals' diversified product offerings. The Chief Operating Officer- CSBU's strategic initiatives aim to expand the market presence of consumer health products through efficient manufacturing and targeted marketing efforts. By overseeing the CSBU's operations, Dave supports the company's broader mission of providing comprehensive health and wellness solutions.
Prabodh Joshi - Group President, Human Resources & Corporate Communications
Prabodh Joshi, the Group President, Human Resources & Corporate Communications at Cadila Pharmaceuticals, leads the strategic direction for talent management and organizational development. Joshi oversees all human resources functions, including recruitment, employee relations, and performance management, ensuring a skilled and motivated workforce. This executive also directs corporate communications, shaping the company's public image and stakeholder engagement strategies. Prabodh Joshi plays a vital role in fostering a positive corporate culture that aligns with Cadila Pharmaceuticals' values and mission. The Group President, Human Resources & Corporate Communications' focus is on attracting and retaining top talent, essential for driving innovation in the pharmaceutical sector. By managing internal and external communications, Joshi ensures consistent messaging and strengthens the company's brand reputation.
Dr Anil - Joint President
Dr Anil, the Joint President at Cadila Pharmaceuticals, contributes to the strategic leadership and operational oversight of key business areas. Anil supports the executive team in driving the company's integrated pharmaceutical operations, from API manufacturing to finished formulations. This role involves collaborating across departments to ensure efficient product development and market launch processes. Dr Anil's focus is on enhancing operational synergies and supporting the company's commitment to quality and innovation. The Joint President's responsibilities include contributing to strategic planning and execution, ensuring that Cadila Pharmaceuticals meets its growth and development objectives. By working closely with other senior leaders, Anil helps to advance the company's mission of providing accessible healthcare solutions.
Wilton Franca - President - Latam
Wilton Franca, the President - Latam at Cadila Pharmaceuticals, directs the company's strategic initiatives and commercial operations across the Latin American region. Franca is responsible for expanding market presence, driving sales growth, and ensuring regulatory compliance within the Latam markets. This executive oversees the distribution and marketing of Cadila Pharmaceuticals' product portfolio, including APIs, finished formulations, and biotechnology products, tailored to regional needs. Wilton Franca focuses on building strong relationships with local partners and stakeholders to enhance market penetration. The President - Latam's leadership is crucial for adapting global strategies to local market dynamics, thereby maximizing revenue and market share in this key geographic area. Franca's efforts contribute significantly to Cadila Pharmaceuticals' international expansion and success.
Suresh Gupta - President, Branded Business
Suresh Gupta, the President, Branded Business at Cadila Pharmaceuticals, leads the strategic development and commercialization of the company's branded pharmaceutical products. Gupta oversees marketing, sales, and product management for the branded portfolio, ensuring strong market positioning and revenue growth. This executive focuses on enhancing brand visibility and driving demand for Cadila Pharmaceuticals' key therapeutic offerings. Suresh Gupta is responsible for identifying market opportunities and developing innovative strategies to capture market share within the branded segment. The President, Branded Business's leadership ensures that the company's branded products effectively reach healthcare providers and patients, contributing to improved health outcomes. Gupta's strategic direction supports Cadila Pharmaceuticals' commitment to providing high-quality, accessible medicines.
Arani Chatterjee - President
Arani Chatterjee, the President at Cadila Pharmaceuticals, provides strategic leadership and operational oversight across designated business functions. Chatterjee contributes to the company's integrated approach, supporting the manufacturing and distribution of a wide range of pharmaceutical products, including APIs, intermediates, and finished formulations. This role involves collaborating with cross-functional teams to drive efficiency and innovation throughout the product lifecycle. Arani Chatterjee focuses on enhancing operational performance and ensuring adherence to stringent quality standards. The President's responsibilities include supporting strategic planning and execution, aligning departmental goals with Cadila Pharmaceuticals' overarching mission. By contributing to key initiatives, Chatterjee helps advance the company's objective of delivering impactful healthcare solutions globally.
Suresh Balasubramanian - President - Plantations
Suresh Balasubramanian, the President - Plantations at Cadila Pharmaceuticals, directs the operations and strategic development of the company's plantation division. Balasubramanian oversees the cultivation, management, and sustainability practices within the plantation sector, ensuring efficient resource utilization and high-quality output. This executive's focus is on optimizing agricultural processes and contributing to the company's diversified business interests. Suresh Balasubramanian plays a key role in managing the supply chain and logistics related to plantation products, ensuring timely delivery and market readiness. The President - Plantations' leadership supports Cadila Pharmaceuticals' broader operational scope by managing this distinct business segment effectively. Balasubramanian's efforts contribute to the overall stability and growth of the company's varied enterprises.
Ranvir Rana - Head Chief Revenue Officer, Business Development
Ranvir Rana, the Head Chief Revenue Officer, Business Development at Cadila Pharmaceuticals, spearheads revenue generation and strategic business expansion initiatives. Rana identifies and cultivates new market opportunities, forging key partnerships and alliances to drive growth. This executive's purview includes developing and executing commercial strategies that enhance market penetration for Cadila Pharmaceuticals' diverse product portfolio, spanning APIs, formulations, and biotechnology products. Ranvir Rana is instrumental in assessing market trends and adapting business development plans to capitalize on emerging opportunities. The Head Chief Revenue Officer, Business Development's leadership ensures the company's commercial success and sustained revenue growth. By focusing on strategic partnerships and market expansion, Rana strengthens Cadila Pharmaceuticals' global footprint and competitive positioning.
Explore Leadership Teams in Manufacturing
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outcomes and overall quality of life. AbbVies scientific and commercial efforts are concentrated in several core therapeutic areas, including immunology, oncology, neuroscience, eye care, and medical aesthetics, along with other specialty areas where significant unmet medical needs exist. Through these focus areas, the company works to create therapies that help patients manage chronic, serious, and often life-altering diseases.
Company Leadership XY
CL
NR
MS
Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.
Company Leadership TI
SG
SP
CS
Cresco Labs is a multi-state, vertically integrated cannabis company that controls its cultivation, manufacturing, extraction, and packaging practices. Its facilities are powered by agronomists, manufacturing experts, and state-of-the-art agricultural equipment, all of which drive their commitment to quality, purity, and consistency. Cresco Labs packages, ships and distributes its products nationwide, including locations owned and operated by their team. Cresco Labs is headquartered in Chicago, Illinois.
Company Leadership DD
CR
GB
Tabuk Pharmaceuticals is a generic pharmaceutical company that delivers quality cost-effective prices in the regulated markets of the MENA region. The company provides to the major therapeutic areas of GI and diabetes, cardiovascular, musculoskeletal, respiratory, infection, and the central nervous system pharmaceuticals.
Company Leadership IS
DB
HR
Frequently Asked Questions Regarding Cadila Pharmaceuticals Top Executives and Leadership Team
